share_log

中源协和细胞基因工程股份有限公司独立董事关于收购参股子公司合源生物科技(天津)有限公司股东所持部分股权暨关联交易的事前认可意见

Prior approval opinions of the independent director of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the acquisition of some shares held by shareholders of the participating subsidiary Heyuan Biotechnology (Tianjin) Co., Ltd. and related transactio

SZSI ·  Sep 28, 2023 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more